APA (7th ed.) Citation

Mastorino, L., Dapavo, P., Susca, S., Cariti, C., Siliquini, N., Verrone, A., . . . Ribero, S. (2024). Drug survival und klinische Wirksamkeit von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab und Tildrakizumab in der Behandlung der Psoriasis: Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG, 22(1), 34. https://doi.org/10.1111/ddg.15251_g

Chicago Style (17th ed.) Citation

Mastorino, Luca, et al. "Drug Survival Und Klinische Wirksamkeit Von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab Und Tildrakizumab in Der Behandlung Der Psoriasis: Drug Survival and Clinical Effectiveness of Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab, Tildrakizumab for Psoriasis Treatment." Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG 22, no. 1 (2024): 34. https://doi.org/10.1111/ddg.15251_g.

MLA (9th ed.) Citation

Mastorino, Luca, et al. "Drug Survival Und Klinische Wirksamkeit Von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab Und Tildrakizumab in Der Behandlung Der Psoriasis: Drug Survival and Clinical Effectiveness of Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab, Tildrakizumab for Psoriasis Treatment." Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG, vol. 22, no. 1, 2024, p. 34, https://doi.org/10.1111/ddg.15251_g.